Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma
Antineoplastic Combined Chemotherapy Protocols
Soft Tissue Neoplasms
Age, location, nodal status, and histologic subtype do not appear be associated with survival in adults with rhabdomyosarcoma treated with multimodal therapy. Metastatic disease at presentation and poor response to chemotherapy are strongly associated with poor prognosis. Future systemic therapies should be targeted to patients with localized/locoregional disease and partial responders to conventional chemotherapy.